
Enveda Biosciences offers Enveda Drug Discovery Platform
AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.
- Currently Offered

AI-enabled natural-product drug discovery platform organizing plant chemistry into a searchable library with machine-learning translation and automated screening.
The Enveda Drug Discovery Platform analyzes natural samples to determine what the molecules are and what they do, combining a large natural-sample library, proprietary language models on mass spectrometry data including the PRISM foundation model trained on over a billion spectra, and high-throughput screening.
The company reports faster progress to development candidate versus industry averages on this platform, with a wholly owned pipeline as output. The stated forward scope is drug discovery today with possible future application to agriculture, nutrition, manufacturing, and diagnostics.


GEMS (Genesis Exploration of Molecular Space) is a generative AI platform for small-molecule drug discovery.


Generate Platform is a generative biology platform that designs novel protein therapeutics.


Recursion OS is an AI-powered drug discovery and development platform built on massive proprietary biological and chemical datasets.
GEMS (Genesis Exploration of Molecular Space) is a generative AI platform for small-molecule drug discovery.

Generate Platform is a generative biology platform that designs novel protein therapeutics.

Recursion OS is an AI-powered drug discovery and development platform built on massive proprietary biological and chemical datasets.





mBER is Manifold Bio's open-source AI framework for designing antibody binders for in vivo drug discovery.


Cyrus Platform is Cyrus Biotechnology's computational protein design offering combining AI and Rosetta-based design with laboratory mutagenesis screening.


Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.


1910's ITO™ platform orchestrates multimodal AI and lab automation for small and large molecule drug discovery.


A tissue-first platform generating spatial, molecular, and functional maps from patient tumors.


Creation uses Lila Iris and AI Science Factories to generate validated scientific assets and company opportunities.


Catalyst gives partner science teams direct platform access to Lila Iris and AI Science Factories.


Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.
Machine learning platform for drug discovery and development.

Cradle Platform is an AI system that engineers proteins from laboratory data.

mBER is Manifold Bio's open-source AI framework for designing antibody binders for in vivo drug discovery.

Cyrus Platform is Cyrus Biotechnology's computational protein design offering combining AI and Rosetta-based design with laboratory mutagenesis screening.

Biology-First AI platform predicts disease-matched compounds using multi-omics human data and functional validation.

1910's ITO™ platform orchestrates multimodal AI and lab automation for small and large molecule drug discovery.

A tissue-first platform generating spatial, molecular, and functional maps from patient tumors.

Creation uses Lila Iris and AI Science Factories to generate validated scientific assets and company opportunities.

Catalyst gives partner science teams direct platform access to Lila Iris and AI Science Factories.

Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.
